PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
6193871-5	1983	These results indicate that, under these experimental conditions, the double-stranded RNA-dependent adenosine triphosphate:2",5"-oligoadenylic acid adenyltransferase and protein kinase can be induced by IFN-beta in cells treated with bleomycin, vincristine, or mitomycin C.	Bleomycin	234-243	interferon beta 1	Homo sapiens	203-211	
6193871-1	1983	Bleomycin, vincristine, or mitomycin C, when added to HeLa cells simultaneously with human fibroblast interferon (IFN-beta), caused a decrease in cell density and inhibited DNA synthesis compared with HeLa cells treated with IFN-beta alone.	Bleomycin	0-9	interferon beta 1	Homo sapiens	114-122	
6193871-1	1983	Bleomycin, vincristine, or mitomycin C, when added to HeLa cells simultaneously with human fibroblast interferon (IFN-beta), caused a decrease in cell density and inhibited DNA synthesis compared with HeLa cells treated with IFN-beta alone.	Bleomycin	0-9	interferon beta 1	Homo sapiens	225-233	
6193871-3	1983	HeLa cells treated with IFN-beta alone or with IFN-beta in combination with bleomycin, vincristine, or mitomycin C were able to induce the double-stranded RNA-dependent adenosine triphosphate:2",5"-oligoadenylic acid adenyltransferase (EC 2.2.2.-) and the double-stranded RNA-dependent protein kinase.	Bleomycin	76-85	interferon beta 1	Homo sapiens	24-32	
6193871-3	1983	HeLa cells treated with IFN-beta alone or with IFN-beta in combination with bleomycin, vincristine, or mitomycin C were able to induce the double-stranded RNA-dependent adenosine triphosphate:2",5"-oligoadenylic acid adenyltransferase (EC 2.2.2.-) and the double-stranded RNA-dependent protein kinase.	Bleomycin	76-85	interferon beta 1	Homo sapiens	47-55	
6193871-8	1983	The possibility that IFN-beta potentiates the cytotoxic effects of bleomycin and mitomycin C on HeLa cells is also discussed.	Bleomycin	67-76	interferon beta 1	Homo sapiens	21-29	
22595795-9	2012	However, drugs that also increase pro-oxidant species can complement the antitumor efficacy of the hIFNbeta gene and clearly caused potentiated effects (bleomycin, bortezomib, carboplatin, etoposide and vincristine).	Bleomycin	153-162	interferon beta 1	Homo sapiens	99-107